This session will provide a summary of relevant clinical data supporting the use and adoption of minimally invasive and robotic cardiac surgery.

*Unless otherwise noted, speakers have nothing to disclose.

Moderators

Tom Nguyen (Commercial Relationships: Edwards Lifesciences; Consultant Advisory/Board)

T. Sloane Guy

Digital Moderator

Anita Krueger

Presentations:

1. Why Minimally Invasive Cardiac and Robotic Surgery Should be the Gold Standard: Show Me the Data - Mario Castillo-Sang

(Commercial Relationships: Edwards Lifesciences; Consultant Advisory/Board)

2. Surgical Outcomes of Sternotomy Versus Minimally Invasive Mitral Valve Surgery in Intermediate and High-Risk Cohorts: A Propensity Matched Comparison - Mark Helmers

(Commercial Relationships: Cryolife: Consultant Advisory/Board, Speaker Honoraria; Edwards Lifesciences; Consultant Advisory/Board, Speaker Honoraria)

3. Early Discharge After Minimally Invasive Aortic and Mitral Valve Replacement or Repair - Marlena Sabatino, Leonard Lee (Panelist)

4. Robotic Mitral Valve Repair: A Decade's Experience With Echocardiographic Follow-up - Arman Arghami

5. Robotic Totally Endoscopic Coronary Artery Bypass in 539 Patients: Comparison of Outcomes in 2 Eras Based on Predominant Anastomotic Technique - Husam Balkhy

6. Robotic Aortic Valve Replacement: A Possible Transcatheter Alternative - Lawrence Wei

(Commercial Relationships: Intuitive Surgical)

7. Panel Discussion